A.J.P. Yates

Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

H. A. P. Pols, Dieter Felsenberg, David A. Hanley et al. · Osteoporosis International · 1999 · 594 citations

Bone Disease, Bone Health, Low Bone Mass +8

Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis.

Pascale Chavassieux, M. Arlot, C.V. Reda et al. · Journal of Clinical Investigation · 1997 · 522 citations · Full text

Bone Disease, Bone Health, Long-term Effects +12

Prevention of Bone Loss with Alendronate in Postmenopausal Women under 60 Years of Age

David Hosking, Clair E.D. Chilvers, Claus Christiansen et al. · New England Journal of Medicine · 1998 · 487 citations · Full text

Low Body Mass Index Is an Important Risk Factor for Low Bone Mass and Increased Bone Loss in Early Postmenopausal Women

Pernille Ravn, Giovanni Cizza, N. H. Bjarnason et al. · Journal of Bone and Mineral Research · 1999 · 450 citations

Prevention of Bone Loss With Alendronate in Postmenopausal Women Under 60 Years of Age

David Hosking, Clair Chilvers, Claus Christiansen et al. · Obstetrical & Gynecological Survey · 1998 · 211 citations

Literary Theory, Clair E. D., Gynecology +17